Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis

Molecular Immunology

Volumn 45, Issue 1, 2008, Pages 180-189

  Drouin, Elise E ^a   Glickstein, Lisa ^a   Kwok, William W ^b   Nepom, Gerald T ^b   Steere, Allen C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Borrelia burgdorferi; Lyme disease; MHC molecules; Molecular mimicry; T cells

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIGEN; EPITOPE; HLA DR ANTIGEN; MESSENGER RNA; OUTER SURFACE PROTEIN A; PROTEIN MAWD BP; PROTEIN T SPAN7; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BORRELIA BURGDORFERI; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENOME; HUMAN; HUMAN CELL; LYME DISEASE; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SYNOVIOCYTE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; CELL PROLIFERATION; DRUG RESISTANCE, BACTERIAL; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; LIPOPROTEINS; LYME DISEASE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES;

BORRELIA; BORRELIA BURGDORFERI;

EID: 34548227415     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.04.017     Document Type: Article

References (44)

1. Akin E., McHugh G.L., Flavell R.A., Fikrig E., and Steere A.C. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67 (1999) 173-181
2. Ausubel L.J., Kwan C.K., Sette A., Kuchroo V., and Hafler D.A. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 15317-15322
3. Benoist C., and Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?. Nat. Immunol. 2 (2001) 797-801
4. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 114 (2001) 4143-4151
5. Carlson D., Hernandez J., Bloom B.J., Coburn J., Aversa J.M., and Steere A.C. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42 (1999) 2705-2709
6. Chen J., Field J.A., Glickstein L., Molloy P.J., Huber B.T., and Steere A.C. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum. 42 (1999) 1813-1822
7. Dattwyler R.J., Halperin J.J., Volkman D.J., and Luft B.J. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet 1 (1988) 1191-1194
8. Dattwyler R.J., Wormser G.P., Rush T.J., Finkel M.F., Schoen R.T., Grunwaldt E., Franklin M., Hilton E., Bryant G.L., Agger W.A., and Maladorno D. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien. Klin. Wochenschr. 117 (2005) 393-397
9. 161-175 T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. J. Autoimmun. 23 (2004) 281-292
10. Fujinami R.S., and Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230 (1985) 1043-1045
11. Ghosh S., Seward R., Costello C.E., Stollar B.D., and Huber B.T. Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J. Immunol. 177 (2006) 2486-2494
12. Gross D.M., Forsthuber T., Tary-Lehmann M., Etling C., Ito K., Nagy Z.A., Field J.A., Steere A.C., and Huber B.T. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281 (1998) 703-706
13. Hammer J., Bono E., Gallazzi F., Belunis C., Nagy Z., and Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180 (1994) 2353-2358
14. Hammer J., Sturniolo T., and Sinigaglia F. HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. 66 (1997) 67-100
15. Hill C.M., Hayball J.D., Allison A.A., and Rothbard J.B. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147 (1991) 189-197
16. Hill C.M., Liu A., Marshall K.W., Mayer J., Jorgensen B., Yuan B., Cubbon R.M., Nichols E.A., Wicker L.S., and Rothbard J.B. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152 (1994) 2890-2898
17. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., and Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4 (1998) 781-785
18. Iriyama C., Matsuda S., Katsumata R., and Hamaguchi M. Cloning and sequencing of a novel human gene which encodes a putative hydroxylase. J. Hum. Genet. 46 (2001) 289-292
19. Jardetzky T.S., Gorga J.C., Busch R., Rothbard J., Strominger J.L., and Wiley D.C. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9 (1990) 1797-1803
20. Kalish R.A., Leong J.M., and Steere A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61 (1993) 2774-2779
21. Kamradt T., and Volkmer-Engert R. Cross-reactivity of T lymphocytes in infection and autoimmunity. Mol. Divers. 8 (2004) 271-280
22. 161-175-specific T cells in HLA-DRB1*0401-positive patients with Lyme disease. Arthritis Rheum. 54 (2006) S546
23. Kwok W.W., Nepom G.T., and Raymond F.C. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155 (1995) 2468-2476
24. Lengl-Janssen B., Strauss A.F., Steere A.C., and Kamradt T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180 (1994) 2069-2078
25. Maier B., Molinger M., Cope A.P., Fugger L., Schneider-Mergener J., Sonderstrup G., Kamradt T., and Kramer A. Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells. Eur. J. Immunol. 30 (2000) 448-457
26. Matsuda S., Katsumata R., Okuda T., Yamamoto T., Miyazaki K., Senga T., Machida K., Thant A.A., Nakatsugawa S., and Hamaguchi M. Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer. Cancer Res. 60 (2000) 13-17
27. Nelson C.A., Petzold S.J., and Unanue E.R. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1227-1231
28. Nelson C.A., Petzold S.J., and Unanue E.R. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371 (1994) 250-252
29. Nocton J.J., Dressler F., Rutledge B.J., Rys P.N., Persing D.H., and Steere A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330 (1994) 229-234
30. Novak E.J., Liu A.W., Nepom G.T., and Kwok W.W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104 (1999) R63-R67
31. O'Sullivan D., Arrhenius T., Sidney J., Del Guercio M.F., Albertson M., Wall M., Oseroff C., Southwood S., Colon S.M., Gaeta F.C., et al. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 147 (1991) 2663-2669
32. Salazar C.A., Rothemich M., Drouin E.E., Glickstein L., and Steere A.C. Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi. Infect. Immun. 73 (2005) 2951-2957
33. Sette A., Lamont A., Buus S., Colon S.M., Miles C., and Grey H.M. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures. J. Immunol. 143 (1989) 1268-1273
34. Shin J.J., Glickstein L., and Steere A.C. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 56 (2007) 1325-1335
35. Steere A.C. Lyme disease. N. Engl. J. Med. 345 (2001) 115-125
36. Steere A.C., and Angelis S.M. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 54 (2006) 3079-3086
37. Steere A.C., Dwyer E., and Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323 (1990) 219-223
38. Steere A.C., Falk B., Drouin E.E., Baxter-Lowe L.A., Hammer J., and Nepom G.T. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48 (2003) 534-540
39. Steere A.C., and Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4 (2004) 143-152
40. Steere A.C., Klitz W., Drouin E.E., Falk B.A., Kwok W.W., Nepom G.T., and Baxter-Lowe L.A. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J. Exp. Med. 203 (2006) 961-971
41. Steere A.C., Levin R.E., Molloy P.J., Kalish R.A., Abraham III J.H., Liu N.Y., and Schmid C.H. Treatment of Lyme arthritis. Arthritis Rheum. 37 (1994) 878-888
42. Steere A.C., Schoen R.T., and Taylor E. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107 (1987) 725-731
43. Takagi S., Fujikawa K., Imai T., Fukuhara N., Fukudome K., Minegishi M., Tsuchiya S., Konno T., Hinuma Y., and Yoshie O. Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int. J. Cancer 61 (1995) 706-715
44. Trollmo C., Meyer A.L., Steere A.C., Hafler D.A., and Huber B.T. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J. Immunol. 166 (2001) 5286-5291